IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN
Hiddemann, W., Barbui, A.M., Canales Albendea, M.A., Cannell, P.K., Collins, G.P., Dürig, J., Forstpointner, R., Herold, M., Hertzberg, M., Klanova, M., Radford, J.A., Tobinai, K., Burciu, A., FingerlVolume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_106
Date:
June, 2017
File:
PDF, 232 KB
english, 2017